Brightening Eye Formulas

View More

Scope Eyecare Introduces 'Bright Eyes' to Eliminate Red, Tired Eyes

Scope Eyecare's 'Bright Eyes' tackles tired, red eyes for consumers with longer days than most. Methylene blue, which reflects light on the eye's surface to make it brighter, is used in the eye drops to rejuvenate tired, red eyes for a clearer, brighter appearance. 'Bright Eyes' liquid is also a bold, brilliant blue, which is also a result of methylene blue. After a long night of studying, working, or partying, 'Bright Eyes' helps eliminate signs of tiredness without causing irritation.

"Bright Eyes is an innovative blue eye drop that transforms the way we whiten and brighten tired eyes. It’s the first product in Scope Eyecare’s new Optase Life range, building on decades of medical expertise to create a new cosmetic line for the beauty market [...]," said Leah Donnelly, product manager at Scope Eyecare.
Trend Themes
1. Methylene Blue Eye Drops - Scope Eyecare's 'Bright Eyes' eye drops use methylene blue to rejuvenate tired, red eyes for a clearer, brighter appearance.
2. Optase Life Cosmetics - Scope Eyecare's new Optase Life range includes 'Bright Eyes', a cosmetic line for the beauty market that builds on their decades of medical expertise.
3. Eye Fatigue Solutions - Scope Eyecare's 'Bright Eyes' eye drops address the growing need for solutions to alleviate eye fatigue caused by longer days.
Industry Implications
1. Eye Care - Scope Eyecare's 'Bright Eyes' eye drops are a disruptive innovation in the eye care industry, providing a new solution for addressing tired, red eyes.
2. Cosmetics - Scope Eyecare's new Optase Life range, which includes 'Bright Eyes', represents a disruptive innovation in the cosmetics industry by bringing together medical expertise and cosmetic solutions.
3. Health and Wellness - Scope Eyecare's 'Bright Eyes' eye drops are a disruptive innovation in the health and wellness industry, providing a new solution for addressing eye fatigue caused by longer days.

Related Ideas

Similar Ideas
VIEW FULL ARTICLE